Pfizer and BioNTech have begun submitting data to U.S. regulators seeking emergency use authorization of their COVID-19 vaccine for children under the age of 5, despite weaker than expected immune responses in their clinical trial of 2- to 4-year-olds.

#Pfizer #vaccine #News #Reuters #COVID

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en